Who owns Calliditas Therap Adr Rep 2 Ord sponsored adr?

Tip: Access positions for across all investors

Analyze quarterly positions in Calliditas Therap Adr Rep 2 Ord with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Calliditas Therap Adr Rep 2 Ord stock

Who bought or sold Calliditas Therap Adr Rep 2 Ord sponsored adr this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 750k $16M 0% Mar 2024
 View chart
Deutsche Bank Aktiengesellschaft 51k $1.1M 0% Mar 2024
 View chart
Susquehanna International 33k $716k 50% Mar 2024
 View chart
Citadel Advisors 26k $556k 29% Mar 2024
 View chart
Ironwood Investment Management 26k $536k 0% Mar 2024
 View chart
Morgan Stanley 6.0k $144k 157% Mar 2024
 View chart
Federation des caisses Desjardins du Quebec 4.0k $84k 100% Mar 2024
 View chart
Wells Fargo & Company 3.8k $79k 151% Mar 2024
 View chart
Optiver Holding B.V. 2.5k $55k 100% Mar 2024
 View chart
Advisor Group Holdings 1.1k $23k -6% Mar 2024
 View chart
Bank of America Corporation 1.0k $22k 233% Mar 2024
 View chart
Planning Capital Management Corp 877.00 $18k 0% Mar 2024
 View chart
Simplex Trading 671.00 $14k 107% Mar 2024
 View chart
Rhumbline Advisers 164.00 $3.5k 0% Mar 2024
 View chart
Qube Research & Technologies 72.00 $1.6k 0% Mar 2024
 View chart
Tudor Investment Corporation 65.00 $1.4k 100% Mar 2024
 View chart
Missouri Trust & Investment 35.00 $735.000000 0% Mar 2024
 View chart
Nalls Sherbakoff Group 18.00 $464.000400 -49% Dec 2023
 View chart

Who sold out of Calliditas Therap Adr Rep 2 Ord?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Dec 2023 952.00 $25k
Jpmorgan Chase & Co Dec 2023 607.00 $16k
Cutler Dec 2023 100.00 $2.0k